Cargando…
Complete response for advanced liver cancer during sorafenib therapy: Case Report
BACKGROUND: Hepatocellular carcinoma (HCC) is the fifth most common neoplasia in the world. In the past, treatment of advanced HCC with conventional antineoplastic drugs did not result in satisfactory outcomes: recently, in this patient population the oral multikinase inhibitor sorafenib has been ab...
| Autores principales: | , , , , , , , , , , , |
|---|---|
| Formato: | Texto |
| Lenguaje: | English |
| Publicado: |
BioMed Central
2011
|
| Materias: | |
| Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3036648/ https://www.ncbi.nlm.nih.gov/pubmed/21241463 http://dx.doi.org/10.1186/1471-230X-11-4 |